Immuron IMM-529 IND approved by FDA

(NASDAQ:IMRN),(AUST:IMC.AX), Key Points Immuron receives U.S. Food and Drug administration (FDA) approval for IMM-529 Investigational New Drug (IND) application and clinical study may proceed FDA assigned an IND number (032095) for the IMM-529 application IND 32095 is Immuron's Investigational new drug (IND) application for clinical development of IMM-529 as product to specifically prevent or treat […]

Telix to Participate in UBS and Jefferies Global Healthcare Conferences

(AUST:TLX.AX),(NasdaqGM:TLX), MELBOURNE, Australia and INDIANAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will participate in the upcoming UBS Global Healthcare Conference in Palm Beach, FL (U.S.) and in the Jefferies Global Healthcare Conference in London (UK). Kevin Richardson, Chief Executive Officer, Precision Medicine will take part in a

RCCAO Welcomes New Federal Infrastructure Funding

Vaughan, ON, Nov. 05, 2025 (GLOBE NEWSWIRE) — Nadia Todorova, Executive Director of the Residential and Civil Construction Alliance of Ontario (RCCAO), made the following statements in response to the Federal budget 2025: “The 2025 Federal Budget provides reason for optimism for Canada's construction sector, with policy reforms and funding offering the potential to boost

Jabra Expands Meeting Room Portfolio with the Launch of Jabra Scheduler

New scheduling panel helps reduce booking conflicts, optimize meeting space, and create a consistent experience across all Jabra-equipped rooms. Offers instant room status, faster booking, and centralized control for meeting spaces of all sizes. By adding scheduling to its audio and video portfolio, Jabra now offers a complete, single-vendor solution for modern meeting spaces. LOWELL,

The votes are in: Canadians select the 2025 Cashmere Collection winning designer

TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Now in its 22nd year, the 2025 Cashmere Collection once again saw fashion meet compassion with its celebration of Canada's leading design talent and the enduring strength of those affected by breast cancer. This year's campaign marked an exciting milestone with events in both Toronto and Montreal, expanding

Amplify Energy Announces Divestiture of Oklahoma Assets

(NYSE:AMPY), HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today it has entered into a definitive agreement to sell all of its interests in Oklahoma for a total contract price of $92.5 million, subject to customary post-closing adjustments (the “Oklahoma Transaction”). The Oklahoma Transaction

Titan Delivers Strong Q3 Results and Nears Construction Completion of Graphite Facility

(TSX:TI),(OTC US:TIMCF),(Other OTC:TIMCF), GOUVERNEUR, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX: TI, OTCQB: TIMCF(1)) (“Titan” or the “Company”), an existing zinc concentrate producer in upstate New York and an emerging natural flake graphite producer, a key component in the broader rare earths and critical minerals ecosystem, today announced strong financial and

Palvella Therapeutics Announces New QTORIN(TM) Product Candidate, QTORIN(TM) Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies

(NASDAQ:PVLA), DSAP is a premalignant, progressive disease characterized by numerous expanding lesions which significantly impact quality-of-life; no FDA-approved therapies exist for the estimated more than 50,000 diagnosed U.S. patients QTORIN(TM) pitavastatin has the potential to be the first pathogenesis-directed therapy designed to directly inhibit the mevalonate pathway, the causal driver of DSAP, in the pathogenic

GEN Restaurant Group to Hold Third Quarter 2025 Conference Call on Friday, November 7, 2025, at 5:00 p.m. ET

(NasdaqGM:GENK), CERRITOS, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of GEN Korean BBQ, a fast-growing casual dining concept with an extensive menu and signature “grill at your table” experience, will hold a conference call on Friday, November 7, 2025, at 5:00 p.m. Eastern time

Targa Resources Corp. Reports Record Third Quarter 2025 Results and Announces Expectation for a 25% Increase to its 2026 Common Dividend

(NYSE:TRGP), HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“TRGP,” the “Company” or “Targa”) today reported third quarter 2025 results. Third quarter 2025 net income attributable to Targa Resources Corp. was $478.4 million compared to $387.4 million for the third quarter of 2024. The Company reported adjusted earnings before interest, income

Scroll to Top